# Immunosensor Enhanced with Silver Nanocrystals for On-Chip Prostate-Specific Antigen Detection

**Authors:** Timothy A. Okhai, Kefilwe V. Mokwebo, Marlon Oranzie, Usisipho Feleni, Lukas W. Snyman

PMC · DOI: 10.3390/bios15070428 · 2025-07-03

## TL;DR

This paper describes a new electrochemical immunosensor using silver nanocrystals to detect prostate-specific antigens with high sensitivity and selectivity.

## Contribution

The novel contribution is the use of silver nanocrystals to enhance the performance of an on-chip immunosensor for PSA detection.

## Key findings

- The immunosensor detected PSA with a detection limit of 1.14 ng/mL and an R2 of 0.99%.
- The sensor showed good selectivity in the presence of interfering substances like glucose and urea.
- The fabricated immunosensor demonstrated stability and repeatability comparable to existing technologies.

## Abstract

An electrochemical immunosensor for the quantification of prostate-specific antigens (PSAs) using silver nanocrystals (AgNCs) is reported. The silver nanocrystals were synthesized using a conventional citrate reduction protocol. The silver nanocrystals were characterized using scanning electron microscopy (SEM) and field effect scanning electron microscopy (FESEM), X-ray diffraction (XRD), high-resolution transmission electron microscopy (HRTEM), Fourier-transform infrared spectroscopy (FTIR), UV-Vis spectroscopy, and small-angle X-ray scattering (SAXS). The proposed immunosensor was fabricated on a glassy carbon electrode (GCE), sequentially, by drop-coating AgNCs, the electro-deposition of EDC-NHS, the immobilization of anti-PSA antibody (Ab), and dropping of bovine serum albumin (BSA) to prevent non-specific binding sites. Each stage of the fabrication process was characterized by cyclic voltammetry (CV). Using square wave voltammetry (SWV), the proposed immunosensor displayed high sensitivity in detecting PSA over a concentration range of 1 to 10 ng/mL with a detection limit of 1.14 ng/mL and R2 of 0.99%. The immunosensor was selective in the presence of interfering substances like glucose, urea, L-cysteine, and alpha-methylacyl-CoA racemase (AMACR) and it showed good stability and repeatability. These results compare favourably with some previously reported results on similar or related technologies for PSA detection.

## Linked entities

- **Chemicals:** glucose (PubChem CID 5793), urea (PubChem CID 1176), L-cysteine (PubChem CID 581)
- **Diseases:** prostate cancer (MONDO:0005159)

## Full-text entities

- **Genes:** KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}, AMACR (alpha-methylacyl-CoA racemase) [NCBI Gene 23600] {aka AMACRD, CBAS4, P504S, RACE, RM}
- **Chemicals:** Silver (MESH:D012834), citrate (MESH:D019343), glucose (MESH:D005947), EDC-NHS (MESH:C000625275), carbon (MESH:D002244), L-cysteine (MESH:D003545), urea (MESH:D014508)
- **Species:** Bacillus sp. SA (species) [taxon 1168094]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293680/full.md

---
Source: https://tomesphere.com/paper/PMC12293680